In TRIUMPH-1, discontinuation rates due to adverse events were 4.1% on 4 mg, 6.9% on 9 mg, and 11.3% on 12 mg (placebo: 4.9%)
Personalized Plan Get a customized care plan tailored to your unique health profile
Natural compounds like fisetin have also exhibited senolytic activity and are being tested in clinical trials
It also proved beneficial in cellular and animal models of another neurodegenerative disorder, amyotrophic lateral sclerosis (ALS), or Lou Gehrigs disease
Potential benefits of tirzepatide is superior blood sugar control, better weight management and minimized cardiovascular risk
Weight Regain and Cardiometabolic Effects after Withdrawal of Semaglutide: The STEP 1 Trial Extension. Diabetes, Obesity & Metabolism